You are using an outdated browser. Please upgrade your browser to improve your experience.

hepatocellular carcinoma

Disease Summary
Associated Targets (1100)
Tbio

698

Tchem

208

Tdark

122

Tclin

72


Mondo Description A malignant tumor that arises from hepatocytes. Hepatocellular carcinoma is relatively rare in the United States but very common in all African countries south of the Sahara and in Southeast Asia. Most cases are seen in patients over the age of 50 years, but this tumor can also occur in younger individuals and even in children. Hepatocellular carcinoma is more common in males than females and is associated with hepatitis B, hepatitis C, chronic alcohol abuse and cirrhosis. Serum elevation of alpha-fetoprotein occurs in a large percentage of patients with hepatocellular carcinoma. Grossly, hepatocellular carcinoma may present as a single mass, as multiple nodules, or as diffuse liver involvement. Microscopically, there is a wide range of differentiation from tumor to tumor (well differentiated to poorly differentiated tumors). Hepatocellular carcinomas quickly metastasize to regional lymph nodes and lung. The overall median survival of untreated liver cell carcinoma is about 4 months. The most effective treatment of hepatocellular carcinoma is complete resection of the tumor. Lately, an increasing number of tumors have been treated with liver transplantation.
Uniprot Description A primary malignant neoplasm of epithelial liver cells. The major risk factors for HCC are chronic hepatitis B virus (HBV) infection, chronic hepatitis C virus (HCV) infection, prolonged dietary aflatoxin exposure, alcoholic cirrhosis, and cirrhosis due to other causes.
Disease Ontology Description A liver carcinoma that has_material_basis_in undifferentiated hepatocytes.
Mondo Term and Equivalent IDs
MONDO:0007256:  hepatocellular carcinoma
COHD:4001171: 
EFO:0000182: 
MESH:D006528: 
NCIT:C3099: 
ONCOTREE:HCC: 
Orphanet:88673: